The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Growth in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 23,500 shares, a growth of 78.0% from the March 15th total of 13,200 shares. Based on an average daily volume of 28,600 shares, the short-interest ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

CGABL stock traded up $0.05 during trading on Thursday, hitting $16.65. The company had a trading volume of 19,732 shares, compared to its average volume of 24,642. The business has a 50-day moving average of $17.60 and a 200-day moving average of $18.56. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a one year low of $16.43 and a one year high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, February 15th. Investors of record on Saturday, February 1st were issued a $0.2891 dividend. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date of this dividend was Friday, January 31st. This represents a $1.16 annualized dividend and a yield of 6.94%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.